Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 8 | Issue 1 | 2017 | pp. 41–43Open access
Pleural Tuberculosis following Infliximab Therapy for Ankylosing Spondylitis
- 1,
- 1*,
- 1,
- 1,
- 1
- 1 Department of Medicine, Kasturba Medical College, Manipal, Karnataka, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Sharath Madhyastha
Department of Medicine, Kasturba Medical College, Manipal, Karnataka, India.
Email: drsharathymc@gmail.com
Copyright: © 2017 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2017
- Received:
- Nov 16, 2016
- Accepted:
- Jan 26, 2017
How to cite
Krishnan, V. S. G., Madhyastha, S., Ramamoorthi, K., Acharya, R. V., & Gopalaswamy, V. (2017). Pleural Tuberculosis following Infliximab Therapy for Ankylosing Spondylitis. Journal of Pharmacology and Pharmacotherapeutics, 8(1), 41–43. https://doi.org/10.4103/jpp.JPP_174_16
Abstract
We present a case of pleural tuberculosis (TB) in a patient on infliximab for ankylosing spondylitis. A 36-year-old male presented to our hospital with low back ache of inflammatory type along with multiple symmetric inflammatory type of joint pain. Further clinical examination, laboratory and radiological investigations were suggestive of ankylosing spondylitis. He was initially treated with nonsteroidal anti-inflammatory drugs but citing poor response it was decided to initiate biologic therapy using infliximab (antitumor necrosis factor-alpha). Mantoux test and chest radiograph were done before the therapy to rule out TB. Following three doses of infliximab, patient came with complaints of fever and cough for 1 week. On investigation, it was found to be a case of pulmonary TB. This shows the importance of close monitoring of patient for TB among patients on infliximab even though the screening test has come out to be negative.
Keywords
Subject
Article metadata
| Title | Pleural Tuberculosis following Infliximab Therapy for Ankylosing Spondylitis |
|---|---|
| Authors | V. S. Gokul Krishnan; Sharath Madhyastha; Kusugodlu Ramamoorthi; Raviraj V. Acharya; Vinaya Gopalaswamy |
| Affiliations | Department of Medicine, Kasturba Medical College, Manipal, Karnataka, India. |
| Corresponding author | drsharathymc@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 8, Issue 1 (2017) |
Also in this issue
- Eminence or Evidence? The Volatility, Uncertainty, Complexity, and Ambiguity in Healthcarepp. 1–2
- Effect of Addition of Fentanyl and Clonidine to Local Anesthetic Solution in Peribulbar Blockpp. 3–7
- Mechanism Underlying Linezolid‑induced Thrombocytopenia in a Chronic Kidney Failure Mouse Modelpp. 8–13
- Indocyanine Green-001 (ICG-001) Attenuates Wnt/β-catenininduces Myocardial Injury Following Sepsispp. 14–20
- Antianginal Efficacy and Tolerability of Ranolazine as an Add‑on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open‑Label Studypp. 21–27
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026